Royal Bank of Canada Reaffirms Outperform Rating for Inspire Medical Systems (NYSE:INSP)
Inspire Medical Systems (NYSE:INSP – Get Free Report)‘s stock had its “outperform” rating reaffirmed by equities research analysts at Royal Bank of Canada in a research note issued on Tuesday,Benzinga reports. They currently have a $260.00 target price on the stock. Royal Bank of Canada’s price target would suggest a potential upside of 38.91% from […]
![Royal Bank of Canada Reaffirms Outperform Rating for Inspire Medical Systems (NYSE:INSP)](https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/inspire-medical-systems-inc-logo-1200x675.jpg?v=20221114155654&w=240&h=240&zc=2)